Hepavax
Hepavax-Gene is a recombinant Hepatitis B vaccine which is proceeded in
isolation room to guarantee the quality of immunization system. The HBsAg
(Hepatitis B surface antigent) administration to the body will induce the
immunization system to produce antibody against the virus.
Composition
Per ml vial contains :
Hepatitis B surface antigent (recombinant) 20 mcg
Indication
Active immunization against infection caused by Hepatitis B virus
Contra Indication
Severe febrile infections; hypersensitivity
Warning
Pregnancy
Adverse Reaction
Local reaction at injection-site; malaise; fever; headache; nausea; dizziness
Dosage
Adult & children > 10 years : 20 mcg IM deltoid at 0, 1, 6 months
Children < 10 years : 10 mcg IM anterolateral thigh at the same schedule
Presentation
Adult vial 20 mcg/ml
Paediatric vial 10 mcg/ml